Gene-based vaccines and immunotherapeutics (Q35873176)

10 August 2017

1 reference

title

Gene-based vaccines and immunotherapeutics (English)

1 reference

10 August 2017

1 reference

Margaret Liu

1

1 reference

10 August 2017

Bruce Acres

2

1 reference

10 August 2017

Jean-Marc Balloul

3

1 reference

10 August 2017

Nadine Bizouarne

4

1 reference

10 August 2017

Stephane Paul

5

1 reference

10 August 2017

Philippe Slos

6

1 reference

10 August 2017

Patrick Squiban

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

27 August 2004

1 reference

Proceedings of the National Academy of Sciences of the United States of America

10 August 2017

1 reference

10 August 2017

101 Suppl 2

1 reference

10 August 2017

14567-14571

1 reference

Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Antibodies to human milk fat globule molecules

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Nonreplicating vaccinia vector efficiently expresses recombinant genes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.0404845101

Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=521989

Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium

24 September 2018

1 reference

12 December 2020

Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity

1 reference

12 December 2020

Anti-colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes

1 reference

12 December 2020

Immunological analysis of mucin molecules expressed by normal and malignant mammary epithelial cells

1 reference

12 December 2020

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies

1 reference

12 December 2020

Loss of HLA class I expression in prostate cancer: implications for immunotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0404845101

1 reference

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

15333750

1 reference